Htn
Antihypertensive Selection
search
Antihypertensive Selection
, Hypertension Monotherapy
See Also
Hypertension
Hypertension Causes
Hypertension Evaluation
Hypertension Evaluation History
Evaluation Exam
Hypertension Evaluation Labs
Isolated Systolic Hypertension
Hypertension Management
Hypertension Risk Stratification
Resistant Hypertension
Hypertension Management for Specific Comorbid Diseases
Hypertension Management for Specific Populations
Hypertension Management for Specific Emergencies
Hypertension in Children
Hypertension in Infants
Hypertension in Pregnancy
Hypertension in Athletes
Hypertension in the Elderly
Protocol
Step 1 (Determine when and how to intervene)
Review
Hypertension Risk Stratification
Determine
Hypertension Reduction Goal
Protocol
Step 2
Consider
Hypertension Combination Therapy
For
Refractory Hypertensive Populations
Combination therapy to start appears to be more effective than starting with monotherapy
Choose agents first based on comorbidity and cohort
See
Hypertension Management for Specific Comorbid Diseases
See
Hypertension Management for Specific Populations
Monotherapy (when not otherwise directed by comorbidity or cohort)
Consider starting with combination tablet
Lisinopril
/Hctz 20/25 mg (Kaiser-Permanante)
http://providers.kaiserpermanente.org/info_assets/cpp_cod/cod_adult_bp_clinician_guide.pdf
Allows for dosing at 1/2 tablet (10/12.5 mg), 1 tablet, or 2 tablets (40/50 mg)
Standard initial monotherapy choices
Diuretic
s (e.g.
Hydrochlorothiazide
)
If
Diuretic
is not first, it should be second
Excellent adjunct to other antihypertensives
Better outcomes than
Lisinopril
and
Amlodipine
Reduced risk of CVA, MI, CHF over other agents
(2002) JAMA 288:2981-97 [PubMed]
ACE Inhibitor
or
Angiotensin Receptor Blocker
Preferred first-line agent in age under 60 years old
Calcium Channel Blocker
s
Compelling reason for other antihypertensive
AntiHypertensives for Specific Comorbid Diseases
Antihypertensives for Specific Populations
Agents to avoid for monotherapy
Alpha blockers
Hydralazine
Minoxidil
Beta Blocker
Trend is to avoid
Beta Blocker
s as first-line agents in uncomplicated
Hypertension
Reserve for patients with
Coronary Artery Disease
or
Congestive Heart Failure
Avoid if non-compliant (rebound
Hypertension
)
Beta Blocker
s
Clonidine
Protocol
Step 3
Consider
Hypertension Combination Therapy
Metabolism
Antihypertensives not affected by
Cytochrome P450
system
Angiotensin Receptor Blocker
s
Valsartan
Eprosartan
Candesartan
Diuretic
s
Hydrochlorothiazide
Furosemide
Alpha-adrenergic agents
Prazosin
Clonidine
Type your search phrase here